Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adff709a8d25eaa0d3871ff46ff250eb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2016-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae311b7e57ab0865112910f679d9c9a9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3563ab6695fcd7804ee8ee1a96b17ad1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6136ab1b2ec8dfedf575d170e7b27c0 |
publicationDate |
2017-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2017036341-A |
titleOfInvention |
Methods and uses for inducing apoptosis in cancer cells |
abstract |
A method for inducing apoptosis in cancer cells by delivering an exogenous coenzyme or a metabolite thereof in a pharmaceutically acceptable carrier. Induction of apoptosis in cancer cells by, but not limited to, inducing cellular contact of endogenous coenzyme Q10 or its metabolites in addition to mevalonic acid and oleic acid to form intracellular complexes how to. A method of modulating the p53 pathway and the Bcl-2 protein family in a manner that restores the apoptotic potential to cancer cells by delivery of coenzyme Q10 in a pharmaceutically acceptable carrier. Furthermore, a method of specifically normalizing the ratio of pro- and anti-apoptotic members of the Bcl-2 gene family at a rate that reprograms cancer cells to undergo apoptosis. [Selection] Figure 2 |
priorityDate |
2008-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |